165 related articles for article (PubMed ID: 14960057)
21. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter closure of patent foramen ovale in older adults.
Kiblawi FM; Sommer RJ; Levchuck SG
Catheter Cardiovasc Interv; 2006 Jul; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
[TBL] [Abstract][Full Text] [Related]
23. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting.
Giardini A; Donti A; Formigari R; Salomone L; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
Am Heart J; 2006 Apr; 151(4):922.e1-5. PubMed ID: 16569564
[TBL] [Abstract][Full Text] [Related]
24. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
Bédard E; Rodés-Cabau J; Houde C; Mackey A; Rivest D; Cloutier S; Noël M; Marrero A; Côté JM; Chetaille P; Delisle G; Leblanc MH; Bertrand OF
Stroke; 2007 Jan; 38(1):100-4. PubMed ID: 17122434
[TBL] [Abstract][Full Text] [Related]
25. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
Spies C; Khandelwal A; Timmermanns I; Schräder R
Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
[TBL] [Abstract][Full Text] [Related]
26. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
[TBL] [Abstract][Full Text] [Related]
27. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
[TBL] [Abstract][Full Text] [Related]
28. Postoperative pulmonary arteriovenous fistula resulting in recurrent cryptogenic stroke.
Fateh-Moghadam S; Dietz R; Bocksch W
Int J Cardiol; 2007 Apr; 117(1):e43-5. PubMed ID: 17198738
[TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure.
Dodge SM; Hassell K; Anderson CA; Keller J; Groves B; Carroll JD
Catheter Cardiovasc Interv; 2004 Jan; 61(1):123-7. PubMed ID: 14696171
[TBL] [Abstract][Full Text] [Related]
30. Association of interatrial shunts and migraine headaches: impact of transcatheter closure.
Azarbal B; Tobis J; Suh W; Chan V; Dao C; Gaster R
J Am Coll Cardiol; 2005 Feb; 45(4):489-92. PubMed ID: 15708691
[TBL] [Abstract][Full Text] [Related]
31. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
32. Ischemic stroke during sexual intercourse: a report of 4 cases in persons with patent foramen ovale.
Becker K; Skalabrin E; Hallam D; Gill E
Arch Neurol; 2004 Jul; 61(7):1114-6. PubMed ID: 15262745
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous closure of patent foramen ovale: pathophysiology, indications, and technique.
Danzi GB; Sesana M; Capuano C; Baglini R
Neurol Sci; 2003 May; 24 Suppl 1():S17-9. PubMed ID: 12774205
[TBL] [Abstract][Full Text] [Related]
34. Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation.
Narayan V; Puri P; Mehra AO
J Invasive Cardiol; 2008 Aug; 20(8):E247-9. PubMed ID: 18688073
[TBL] [Abstract][Full Text] [Related]
35. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
Rigatelli G; Giordan M; Braggion G; Aggio S; Chinaglia M; Zattoni L; Milan T; Cardaioli P
Cardiovasc Revasc Med; 2007; 8(4):248-50. PubMed ID: 18053946
[TBL] [Abstract][Full Text] [Related]
36. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder.
Spies C; Strasheim R; Timmermanns I; Schraeder R
Eur Heart J; 2006 Feb; 27(3):365-71. PubMed ID: 16254007
[TBL] [Abstract][Full Text] [Related]
37. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
Spies C; Reissmann U; Timmermanns I; Schräder R
J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672
[TBL] [Abstract][Full Text] [Related]
38. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.
Majunke N; Baranowski A; Zimmermann W; Heinisch C; Wilson N; Robertson G; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2009 Feb; 73(3):376-82. PubMed ID: 19085919
[TBL] [Abstract][Full Text] [Related]
39. [Patent foramen ovale. What is it and what does it indicate?].
Serena J
Neurologia; 2006 Dec; 21(10):689-94. PubMed ID: 17106821
[TBL] [Abstract][Full Text] [Related]
40. PFO and stroke: what are the data?
Wechsler LR
Cardiol Rev; 2008; 16(1):53-7. PubMed ID: 18091402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
